Pharma & Bio
Lifestyle
The Key to the Era of Precision Medicine Is ‘Securing Real-World Clinical Data’… Macrogen, Inc. and NGeneBio Co., Ltd. Expected to Benefit
Cancer treatment is increasingly shifting toward a model where the patient’s tumor genes are analyzed to select the most appropriate therapy. Consequently, the key factor determining the competitivene…
Lifestyle
[Blue Ocean Veterinary Medical Devices] ③ RecensMedical, Inc. Draws Attention with Veterinary Cooling Devices… Targeting a Niche Market
As medical technology advances, the treatment of human diseases is evolving toward “personalized” and “precision medicine.” Consequently, demand for personalized treatment and precision medicine is no…
Technology
HLB INC. Prepares for U.S. Commercialization Even Before Liver Cancer Drug Approval… Hires Staff for Insurance Coverage
Excerpts from Eleva Therapeutics’ job postings. They specify tasks such as securing U.S. insurance coverage for the combination therapy of riboceranib and camrelizumab, as well as for lirapugratinib. …
Lifestyle
Kolon Plummets on TG-C Failure; NGeneBio Soars [K-bio pulse]
Shares of three Kolon Group affiliates plummeted Tuesday after Kolon TissueGene’s osteoarthritis cell and gene therapy TG-C—formerly known as Invossa—failed a late-stage U.S. clinical trial. Kolon Tis…
Lifestyle
KOLON CORPORATION’s Three Subsidiaries Plunge on ‘TG-C’ News… NGeneBio Co., Ltd. Rises [Bio Market Watch]
On the 21st, shares in the pharmaceutical and biotech sector plummeted to the daily limit-down following news of the clinical failure of “TG-C” (formerly Invossa), a cell-gene therapy for osteoarthrit…
Technology
“Aiming to Stabilize Supply Chains”… Tax Credits for Biotech Raw Materials and Supplies; CDMOs to Benefit the Most
The government is pushing forward with a plan to designate key raw materials and components necessary for the production of biopharmaceuticals and vaccines as strategic goods and to provide tax credit…
Technology
Alteogen Inc., Which Aimed for a '30 Trillion Valuation,' Remains on KOSDAQ After 7 Months… Beneficiaries of the Promotion-Demotion System
Alteogen Inc.(196170), the company with the largest market capitalization on KOSDAQ, has tentatively put on hold its plans to relist on the Korea Exchange (KOSPI) and opted to remain on KOSDAQ. This c…
Lifestyle
[Blue Ocean Veterinary Medical Devices] (2) RAYENCE CO., LTD. Subsidiary Woori-En Holds Overwhelming Lead in the Veterinary Electronic Medical Record Market
As medical technology advances, the treatment of human diseases is evolving toward “personalized” and “precision medicine.” Consequently, demand for personalized treatment and precision medicine is no…
Technology
Curiosis Inc.’s “Two-Track” Supply Contract… Is a Turnaround in Earnings Possible?
(Graphic: ChatGPT)
#Curiosis Inc. has secured a German company, M, as a client following global life sciences firm Revvity Biomed, marking its expansion into the Original Design Manufacturing (ODM…
Lifestyle
Chasing High Returns Despite Risks? Three "Problematic" Biotech Stocks Rank Among the Top 15 Gainers [K-Bio Pulse]
As the domestic stock market enters a correction phase, excess liquidity is flowing back into the pharmaceutical and biotech sectors. Investors are even returning to companies previously labeled as “p…